Early Breast Cancer Trialists Collaborative Group. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 2012;379(9814):432–444.

• PubMed
Early Breast Cancer Trialists Collaborative Group. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 2012;379(9814):432–444.)| false
• Search Google Scholar
• Export Citation

Stabellini N, Cao L, Towe CW, et al. Validation of the PREDICT prognostication tool in US breast cancer patients. J Natl Compr Canc Netw 2023;21:1011–1019.

• PubMed
Stabellini N, Cao L, Towe CW, Validation of the PREDICT prognostication tool in US breast cancer patients. J Natl Compr Canc Netw 2023;21:1011–1019.)| false
• Search Google Scholar
• Export Citation

Candido Dos Reis FJ, Wishart GC, Dicks EM, et al. An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation. Breast Cancer Res 2017;19:58.

• PubMed
Candido Dos Reis FJ, Wishart GC, Dicks EM, An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation. Breast Cancer Res 2017;19:58.)| false
• Search Google Scholar
• Export Citation

Wishart GC, Azzato EM, Greenberg DC, et al. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res 2010;12:R1.

• PubMed
Wishart GC, Azzato EM, Greenberg DC, PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer. Breast Cancer Res 2010;12:R1.)| false
• Search Google Scholar
• Export Citation

Wishart GC, Bajdik CD, Azzato EM, et al. A population-based validation of the prognostic model PREDICT for early breast cancer. Eur J Surg Oncol 2011;37:411–417.

• PubMed
Wishart GC, Bajdik CD, Azzato EM, A population-based validation of the prognostic model PREDICT for early breast cancer. Eur J Surg Oncol 2011;37:411–417.)| false
• Search Google Scholar
• Export Citation

Zaguirre K, Kai M, Kubo M, et al. Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients. Cancer Med 2021;10:1605–1613.

• PubMed
Zaguirre K, Kai M, Kubo M, Validity of the prognostication tool PREDICT version 2.2 in Japanese breast cancer patients. Cancer Med 2021;10:1605–1613.)| false
• Search Google Scholar
• Export Citation

Wong HS, Subramaniam S, Alias Z, et al. The predictive accuracy of PREDICT: a personalized decision-making tool for Southeast Asian women with breast cancer. Medicine (Baltimore) 2015;94:e593.

• PubMed
Wong HS, Subramaniam S, Alias Z, The predictive accuracy of PREDICT: a personalized decision-making tool for Southeast Asian women with breast cancer. Medicine (Baltimore) 2015;94:e593.)| false
• Search Google Scholar
• Export Citation

de Glas NA, Bastiaannet E, Engels CC, et al. Validity of the online PREDICT tool in older patients with breast cancer: a population-based study. Br J Cancer 2016;114:395–400.

• PubMed
de Glas NA, Bastiaannet E, Engels CC, Validity of the online PREDICT tool in older patients with breast cancer: a population-based study. Br J Cancer 2016;114:395–400.)| false
• Search Google Scholar
• Export Citation

Engelhardt EG, van den Broek AJ, Linn SC, et al. Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years. Eur J Cancer 2017;78:37–44.

• PubMed
Engelhardt EG, van den Broek AJ, Linn SC, Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years. Eur J Cancer 2017;78:37–44.)| false
• Search Google Scholar
• Export Citation

van Maaren MC, van Steenbeek CD, Pharoah PDP, et al. Validation of the online prediction tool PREDICT v. 2.0 in the Dutch breast cancer population. Eur J Cancer 2017;86:364–372.

• PubMed
van Maaren MC, van Steenbeek CD, Pharoah PDP, Validation of the online prediction tool PREDICT v. 2.0 in the Dutch breast cancer population. Eur J Cancer 2017;86:364–372.)| false
• Search Google Scholar
• Export Citation

Maishman T, Copson E, Stanton L, et al. An evaluation of the prognostic model PREDICT using the POSH cohort of women aged 40 years at breast cancer diagnosis. Br J Cancer 2015;112:983–991.

• PubMed
Maishman T, Copson E, Stanton L, An evaluation of the prognostic model PREDICT using the POSH cohort of women aged 40 years at breast cancer diagnosis. Br J Cancer 2015;112:983–991.)| false
• Search Google Scholar
• Export Citation

Gray E, Marti J, Brewster DH, et al. Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data. Br J Cancer 2018;119:808–814.

• PubMed
Gray E, Marti J, Brewster DH, Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data. Br J Cancer 2018;119:808–814.)| false
• Search Google Scholar
• Export Citation

Clift AK, Dodwell D, Lord S, et al. Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study. BMJ 2023;381:e073800.

• PubMed
Clift AK, Dodwell D, Lord S, Development and internal-external validation of statistical and machine learning models for breast cancer prognostication: cohort study. BMJ 2023;381:e073800.)| false
• Search Google Scholar
• Export Citation

Chowdhury A, Pharoah PD, Rueda OM. Evaluation and comparison of different breast cancer prognosis scores based on gene expression data. Breast Cancer Res 2023;25:17.

• PubMed
Chowdhury A, Pharoah PD, Rueda OM. Evaluation and comparison of different breast cancer prognosis scores based on gene expression data. Breast Cancer Res 2023;25:17.)| false
• Search Google Scholar
• Export Citation

Cardoso F, van’t Veer LJ, Bogaerts J, et al. 70-gene signature as an aid to treatment decisions in early-stage breast cancer. N Engl J Med 2016;375:717–729.

• PubMed
Cardoso F, van’t Veer LJ, Bogaerts J, 70-gene signature as an aid to treatment decisions in early-stage breast cancer. N Engl J Med 2016;375:717–729.)| false
• Search Google Scholar
• Export Citation

Sparano JA, Gray RJ, Makower DF, et al. Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med 2018;379:111–121.

• PubMed
Sparano JA, Gray RJ, Makower DF, Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer. N Engl J Med 2018;379:111–121.)| false
• Search Google Scholar
• Export Citation